Market Research Report

Bahrain Healthcare Market Key Takeaways

The Bahrain healthcare market was estimated at USD 2.30 billion in 2025 and is expected to reach USD 2.36 billion in 2026. Additionally, the industry further projected to grow to approximately USD 2.85 billion by 2032, registering a CAGR of 5.26% over the forecast period.

Out of Bahrain’s total patient population, an estimated 22.1% of individuals are living with diabetes, reflecting its significant burden.

Cardiovascular diseases account for an estimated 14.8% of Bahrain’s total patient population, reflecting a significant public health concern.

Bahrain healthcare system is supported by approximately 1.5 physicians and 3.0 nurses per 1,000 populations, along with around 20–25 hospitals and nearly 2,500–3,000 hospital beds across public and private healthcare facilities. The country also maintains strong diagnostic capabilities, with widespread availability of advanced imaging technologies such as MRI and CT scanners in major tertiary and private hospitals, enabling efficient, technology-enabled healthcare delivery.

Bahrain Healthcare Market Size and Outlook

The Bahrain healthcare market size was valued at USD 2.30 billion in 2025 and is projected to grow from USD 2.36 billion in 2026 to USD 2.85 billion by 2032. Along with this, the market is estimated to grow at a CAGR of around 5.26% during the forecast period, i.e., 2026-32.

The healthcare sector in Bahrain has demonstrated steady expansion, supported by population growth exceeding 1.5 million and rising service utilization across both public and private systems. According to the Information & eGovernment Authority, non-communicable diseases account for the majority of healthcare demand, with diabetes prevalence increasing and cardiovascular conditions remaining a leading cause of mortality. The country maintains over 10 government hospitals and 24 private hospitals, reflecting continuous infrastructure upgrades aligned with national health priorities. Additionally, increasing patient volumes, particularly among aging populations and expatriates, are reinforcing demand for specialized care and advanced treatment facilities.

The epidemiological landscape in Bahrain is undergoing a clear transition, marked by a growing prevalence of chronic and lifestyle-related conditions alongside a persistent burden of inherited disorders such as sickle cell disease and thalassemia. This dual disease burden is placing increasing pressure on the healthcare system to expand both preventive and long-term care capabilities. In particular, Bahrain records one of the higher regional incidences of genetic blood disorders, which has prompted the Ministry of Health Bahrain to strengthen nationwide screening and early diagnostic programs. These initiatives are aimed at improving early detection rates and reducing disease-related complications over time.

At the same time, the country is witnessing a steady rise in oncology cases, with breast and colorectal cancers emerging as some of the fastest-growing segments. This trend is driving increased investment in advanced diagnostic technologies, including radiology and precision medicine, to enable more accurate and timely treatment interventions. Collectively, these evolving disease patterns are accelerating demand for tertiary care services, specialized treatment centers, and integrated long-term disease management infrastructure, thereby reshaping Bahrain’s healthcare delivery landscape.

Government-led initiatives under the National Health Plan 2016–2025, along with the ongoing rollout of the Sehati Program Bahrain, are playing a central role in transforming healthcare financing and accessibility across the country. These reforms are collectively driving a structural shift toward mandatory health insurance, which is expanding private sector participation while simultaneously enhancing service quality through increased competition among providers. Additionally, Bahrain is positioning itself as a regional pharmaceutical and medical logistics hub, supported by regulatory reforms from the National Health Regulatory Authority that streamline drug approvals and encourage localized manufacturing and distribution.

Technological integration is becoming a defining growth driver, particularly with the adoption of artificial intelligence in diagnostics, imaging, and hospital management systems. Bahrain’s government hospitals have partnered with national AI institutions to deploy artificial intelligence in predictive disease detection, patient flow forecasting, and treatment optimization, enabling early diagnosis of chronic and genetic conditions while improving operational efficiency. Institutional end-users, including government hospitals and private healthcare groups, are driving capital investment in digital health, telemedicine, and electronic medical records. Looking ahead to 2032, sustained policy support, rising healthcare expenditure, and innovation-led service delivery are expected to reinforce Bahrain’s position as a high-quality, technology-enabled healthcare market in the Gulf region.

Bahrain Healthcare Market Scope

Category	Segments
By Healthcare Expenditure Type	(Public Healthcare Expenditure, Private Healthcare Expenditure, Out-of-Pocket Expenditure),
By Pharmaceutical Segment	(Prescription Drugs, Over-the-Counter (OTC) Drugs, Generic Drugs, Branded Drugs, Biologics & Biosimilars),
By Therapeutic Area	(Cardiovascular Diseases, Oncology, Diabetes, Respiratory Diseases, Neurology, Infectious Diseases, Others),
By Medical Device Type	(Diagnostic Imaging Devices, Patient Monitoring Devices, Surgical Equipment, In-vitro Diagnostics, Orthopedic Devices, Cardiovascular Devices, Others),
By Technology Type	(Artificial Intelligence in Healthcare, Telemedicine & Remote Monitoring, Electronic Health Records (EHR), Healthcare Analytics, Robotic Surgery, Wearables & Health Apps),
By Healthcare Workforce	(Physicians, Nurses, Dentists, Allied Health Professionals),
By Insurance Type	(Public Health Insurance, Private Health Insurance),
By Disease Category	(Chronic Diseases, Infectious Diseases, Mental Health Disorders),
By End User	(Hospitals, Clinics, Diagnostic Centers / Laboratories, Ambulatory Surgical Centers, Home Healthcare, Research Institutes, Pharmacies, Others)

Bahrain Healthcare Market Growth Drivers

Rising Non-Communicable Disease Burden Driving Demand for Specialty and Chronic Care Services

The increasing prevalence of chronic and hereditary diseases has emerged as a structural driver accelerating the healthcare market growth across Bahrain. Non-communicable diseases account for approximately 75% of total mortality in Bahrain, with cardiovascular diseases, diabetes, cancer, and chronic respiratory conditions representing the dominant disease burden.

Simultaneously, Bahrain records a notably high prevalence of hereditary blood disorders, with approximately 2% of newborns affected by sickle cell disease, while nearly 18% of the population carries the sickle cell trait and around 24% are carriers of thalassemia , highlighting a significant genetic disease burden in the country. This dual disease burden has intensified over time due to demographic shifts, sedentary lifestyles, and genetic predisposition, creating sustained pressure on healthcare systems.

The measurable impact of this driver is reflected in increased demand across hospitals, specialty clinics, and long-term care facilities, particularly within institutional end-users. Public healthcare providers are expanding capacity for dialysis, cardiology, and oncology services, while private hospitals are investing in specialized treatment centers to address rising case volumes. For example, Bahrain reported 4,547 dialysis patients and over 47,000 treatment visits, showing heavy demand pressure on facilities. To address this, the government is planning new dialysis units at regional health centers e.g., Sheikh Jaber Health Centre to reduce travel burden and decentralize care.

Bahrain Specialist Hospital established the Apollo Heart Center, performing over 1,000 cardiac procedures supported by advanced catheterization laboratory infrastructure . The hospital further strengthened its capabilities through a collaboration with Apollo Hospitals to introduce advanced cardiac surgeries and interventional cardiology expertise in Bahrain.

Moreover, the disease burden directly expands healthcare market size by increasing the total number of patients requiring ongoing care and complex interventions. The long-term nature of these conditions drives consistent utilization of healthcare services, including diagnostics, therapeutics, and rehabilitation, thereby generating sustained revenue streams. As a result, the rising burden of chronic and genetic diseases remains a fundamental driver of healthcare demand expansion in Bahrain through 2032.

Recent Trends

Digital Health Integration and AI Adoption Reshaping Healthcare Service Delivery in Bahrain

Bahrain’s healthcare industry is witnessing a structural transformation through accelerated digital health integration and artificial intelligence adoption across care delivery systems. This trend has gained momentum due to government-led initiatives such as the National Health Information System (I-SEHA) and regulatory support from the Supreme Council of Health. In 2025–2026, expanded deployment of AI-enabled diagnostics, electronic health records, and telemedicine platforms has improved clinical accuracy and service accessibility. The growing need to manage rising chronic disease burden and optimize healthcare expenditure has further reinforced this shift toward technology-driven care models.

The integration of digital platforms and AI is fundamentally reshaping operational structures across providers, payers, and patients. Hospitals and clinics are leveraging predictive analytics for early disease detection, while insurers are incorporating data-driven tools to enhance claims efficiency and risk assessment. For instance , Al Hilal Healthcare Group introduced the GCC’s first AI-powered MRI system in 2026 in partnership with Fujifilm, the system uses AI to enhance image quality, detect abnormalities faster, and support radiologists in diagnosis, it also includes AI-enabled CT scans and digital X-ray systems to improve diagnostic precision and workflow speed Telehealth services are enabling remote consultations and continuous patient monitoring, reducing pressure on physical infrastructure . Simultaneously, private healthcare providers are aligning with national digital frameworks, fostering interoperable systems and enabling seamless information exchange across the healthcare ecosystem.

This trend is expected to persist due to strong policy continuity, sustained public investment, and measurable efficiency gains across the system. Government-backed digital transformation strategies and AI adoption frameworks ensure long-term scalability and compliance. This will lead to increasing patient expectations for accessible and personalized care, combined with demographic and epidemiological pressures, that will continue to drive adoption. As a result, digital health and AI integration will remain central to Bahrain’s healthcare evolution, shaping more efficient, predictive, and patient-centric service delivery models.

Bahrain Healthcare Market Opportunities and Challenges

High Dependence on Imported Medicines Creating Cost, Supply, and Localization Pressures in Bahrain’s Pharma Market

Bahrain’s high dependence on imported pharmaceuticals presents a structural challenge that is simultaneously creating a significant opportunity for local manufacturing development. Heavy reliance on external suppliers exposes the healthcare system to supply disruptions, price fluctuations, and geopolitical risks, particularly during global crises. UN Comtrade data indicates that Bahrain imported adhesive medical dressings worth USD 2.26 million at a volume of 64,062 kilograms, while medical oxygen imports reached 172,056 cubic metres valued at USD 54,720. These import volumes across both routine consumables and critical clinical gases demonstrate Bahrain’s reliance on external suppliers to meet essential healthcare demand.

In response, the National Health Regulatory Authority has introduced regulatory reforms to accelerate drug approvals and encourage domestic production . This supply vulnerability is directly pushing policymakers to prioritize pharmaceutical localization as part of broader economic diversification efforts.

Efforts to reduce import reliance are encouraging public-private partnerships, contract manufacturing, and infrastructure expansion across industrial zones. Bahrain’s strategic location within the Gulf region strengthens its potential to act as a redistribution hub for neighbouring markets, transforming a supply weakness into a logistics advantage. As a result, the value chain is gradually shifting toward integrated manufacturing, storage, and re-export operations, supported by government incentives and foreign investment policies. In 2025, Bahrain introduced a policy allowing factories to import raw materials duty-free. This lowers production costs and encourages pharmaceutical and industrial manufacturing investment. The policy is specifically aimed at strengthening local production and reducing import dependence.

Bahrain is actively proposing a dedicated pharmaceutical manufacturing zone to scale domestic drug production. The initiative includes incentives to attract large-scale manufacturers and boost local capacity, this proposal explicitly links local production expansion with supply security and economic growth. Moreover, Companies such as Gulf Biotech, Bahrain Pharma, and Julphar are already operating manufacturing and contract production facilities, these facilities produce tablets, capsules, and syrups, supporting local production and regional supply. Expansion of contract manufacturing directly contributing to job creation and industrial capability building.

Overall, Bahrain’s import dependence is evolving from a structural vulnerability into a strategic catalyst, driving policy reforms and investments that are steadily strengthening domestic pharmaceutical manufacturing capacity and positioning the country as an emerging regional supply and distribution hub.

Epidemiology Profile

Diabetes

Diabetes represents the most dominant condition within Bahrain healthcare sector analysis and epidemiological profile, driven by high prevalence and sustained incidence linked to lifestyle and demographic transitions. According to the International Diabetes Federation, Bahrain continues to record one of the highest diabetes prevalence rates in the Gulf region, reflecting rising obesity and sedentary behavior. Out of 1,000 people 197.6 people are suffering from diabetes in Bahrain, therefor prevalence is 22.1%.

This dominance is structurally reinforced by strong policy focus and Bahrain healthcare growth drivers supported by targeted healthcare investments and Bahrain healthcare investment opportunities. National strategies supported by the Ministry of Health Bahrain emphasize diabetes prevention, early diagnosis, and long-term disease management through primary care expansion. Substantial investment in specialized clinics, digital monitoring systems, and chronic disease programs has improved treatment access. Additionally, insurance coverage expansion and public awareness campaigns are driving higher diagnosis and treatment rates, sustaining demand across healthcare services.

The treatment landscape for diabetes in Bahrain is well-developed, supported by advanced infrastructure and continuous pharmaceutical demand. Specialized centers such as Bahrain Specialist Hospital are playing a critical role in strengthening diabetes treatment outcomes through integrated, multidisciplinary care delivery. These facilities provide comprehensive services including insulin therapy, continuous glucose monitoring, nutritional counseling, and lifestyle management under a single clinical framework. By combining endocrinology, diagnostics, and patient education, they enable structured and personalized treatment pathways tailored to individual patient profiles. Clinics such as Al Nakheel Medical Centre provide insulin pump therapy and HbA1c testing, enables continuous glucose control and precision treatment adjustments.

Hospitals such as Royal Bahrain Hospital provide advanced endocrinology-led diabetes care focused on the management of complex and long-term complications. These facilities deliver specialized treatment for diabetes-related conditions including kidney disorders , retinopathy, and cardiovascular diseases, ensuring comprehensive clinical oversight. The integration of multi-specialty expertise enables coordinated care for patients with high-risk profiles.

Overall, the high prevalence, continuous incidence, and substantial healthcare burden of diabetes supported by strong policy focus, treatment infrastructure, and sustained patient demand firmly establish it as the leading and most resource-intensive segment within Bahrain’s epidemiological profile.

Cardiovascular diseases

Cardiovascular diseases represent a major health burden in Bahrain, accounting for approximately 53.8% of total deaths, according to national non-communicable disease data, with around 1,396 deaths annually attributed to CVDs, confirming it as the leading cause of death in the country. The disease burden is further reflected in a high age-standardized mortality rate of 290 per 100,000 populations, alongside a crude mortality rate of 91 per 100,000 populations and an incidence rate of 1,284 cases per 100,000 populations, while premature mortality (ages 30–70, including major NCDs such as CVDs) stands at 14.8%, indicating significant early-age health impact. This high burden is strongly driven by prevalent risk factors, including hypertension affecting 35.3% of women and 40.1% of men, and a smoking prevalence of 16.2%, which collectively reinforce the sustained dominance of cardiovascular diseases in Bahrain’s epidemiological profile.

This dominance is reinforced by strong policy prioritization and targeted healthcare investments aimed at non-communicable disease management. National strategies led by the Ministry of Health Bahrain emphasize early screening, risk reduction, and expansion of specialized cardiac services. Investments in cardiac centers, catheterization labs, and emergency response systems have strengthened treatment capacity. Additionally, insurance coverage expansion and awareness campaigns are increasing patient inflow, ensuring sustained utilization of cardiovascular diagnostics and treatment services.

The treatment landscape is supported by advanced hospital infrastructure offering interventional cardiology, surgical procedures, and rehabilitation services. For instance, Bahrain has developed a highly centralized and structured cardiac care system where interventional cardiology, cardiac surgery, and cardiac rehabilitation are delivered within coordinated national centres. A key example is the Mohammed Bin Khalifa bin Salman Al Khalifa Cardiac Centre, which functions as a national referral hub for complex cardiovascular cases, integrating diagnosis, intervention, surgery, and rehabilitation under one system, strengthening the Bahrain’s healthcare infrastructure development. This integrated model ensures continuity of care from acute treatment to long-term recovery and follow-up.

Bahrain Healthcare Industry News and Recent Developments

2025: Bahrain and Kuwait sign agreement to boost medical training and affordable health services for residents

Bahrain and Kuwait have signed a healthcare cooperation agreement aimed at improving medical training programs for healthcare professionals and making healthcare services more affordable for residents. The agreement focuses on strengthening collaboration between the two countries in areas such as skill development of medical staff, sharing healthcare expertise, and improving access to quality healthcare services. This initiative is part of broader efforts to enhance healthcare systems across the Gulf region.

Impact analysis: This agreement is expected to strengthen Bahrain’s healthcare sector by improving the availability and quality of trained medical professionals through cross-country collaboration, which directly addresses workforce shortages and enhances clinical expertise within the system. It also supports the expansion of affordable healthcare services, which can increase patient access and overall healthcare utilization in Bahrain. In the long term, this initiative is likely to contribute to improved healthcare infrastructure efficiency, stronger regional integration of health systems in the GCC, and gradual growth in demand for both public and private healthcare services in Bahrain.

2025: Russian pharmaceutical companies plan to localize production in Bahr ain

Russian pharmaceutical companies are exploring plans to set up local drug manufacturing (localization of production) in Bahrain. This means instead of only exporting medicines, Russian firms may establish production facilities or partnerships inside Bahrain to manufacture medicines locally. The initiative is part of broader Bahrain–Russia cooperation aimed at strengthening pharmaceutical trade, improving medicine availability, and expanding Bahrain’s role in regional healthcare and drug supply chains.

Impact analysis: This development can positively impact Bahrain’s healthcare market by increasing domestic pharmaceutical manufacturing capacity, reducing dependency on imports, and improving medicine availability and supply chain stability. It may also attract foreign direct investment (FDI) into Bahrain’s life sciences and pharma sector, creating opportunities for technology transfer, skilled job creation, and R&D collaboration. In the long term, such localization efforts can strengthen Bahrain’s position as a regional pharmaceutical hub and support the growth of its healthcare and biotech ecosystem.

2025: Bahrain’s sovereign fund and SandboxAQ sign deal to speed up drug discovery with AI

Bahrain’s sovereign wealth fund (Mumtalakat) has signed a strategic partnership with AI and quantum technology company SandboxAQ to accelerate drug discovery using advanced artificial intelligence models. The collaboration involves using AI systems trained on physics, chemistry, and biology to identify new drug targets and develop novel therapies more quickly. The project aims to build Bahrain into a regional biotech hub, generate high-value pharmaceutical intellectual property, and leverage local hospital infrastructure and health data for clinical research and trials.

Impact Analysis: This agreement can significantly transform Bahrain’s healthcare and life sciences market by integrating AI-driven drug discovery into its pharmaceutical ecosystem, which reduces R&D timelines and increases innovation efficiency. It is expected to attract high-value foreign investment in biotech and digital health, strengthen Bahrain’s position as an emerging regional biotech hub, and expand clinical research activity within the country. In the long term, this initiative may shift Bahrain’s healthcare market from being service-oriented to innovation- and research-driven, boosting both pharmaceutical output and high-skilled employment in the sector.

2025: M42 and Bahrain Royal Medical Services advance heart and lung transplants

M42 (a UAE-based advanced healthcare group) has partnered with Bahrain’s Royal Medical Services to strengthen heart and lung transplant services for Bahraini patients. Under this collaboration, Bahrain will gain access to highly specialized transplant surgeries through advanced facilities such as Cleveland Clinic Abu Dhabi, along with support for complex patient care, medical training, and knowledge exchange between the two countries. The agreement is part of a broader effort to improve access to advanced tertiary healthcare and strengthen regional medical cooperation.

Impact Analysis: This partnership is expected to significantly enhance Bahrain’s high-end healthcare capabilities by improving access to advanced transplant procedures that are typically limited to highly specialized centers. It strengthens Bahrain’s position within regional healthcare networks by integrating cross-border clinical expertise, which reduces the need for outbound medical travel. The collaboration also supports knowledge transfer, medical training, and advanced clinical research, which can improve long-term healthcare quality and workforce capability. Overall, it contributes to the growth of Bahrain’s tertiary care segment and reinforces its strategy to upgrade complex medical service offerings in collaboration with leading regional healthcare providers.

2025: Ibn Al Nafees Hospital announces the launch of Bahrain’s first-ever Canon MRI scanner

Ibn Al Nafees Hospital in Bahrain has introduced the country’s first Canon MRI scanner, marking a major upgrade in its diagnostic imaging capabilities. The new MRI system uses advanced imaging technology powered by artificial intelligence-based reconstruction, which improves image clarity, reduces scan time, and enhances patient comfort. This installation represents a significant step in bringing high-end medical imaging technology into Bahrain’s private healthcare sector and reflects ongoing investment in modern diagnostic infrastructure.

Impact analysis: This development strengthens Bahrain’s healthcare market by upgrading diagnostic infrastructure, particularly in the radiology and imaging segment. It increases the availability of advanced MRI services locally, reducing the need for patients to travel abroad for high-quality scans. The introduction of next-generation imaging technology also pushes competition among private hospitals to invest in advanced medical equipment, leading to overall modernization of Bahrain’s healthcare ecosystem. In the long term, such investments improve diagnostic accuracy, attract more patients, and support the growth of high-value medical services within the country.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.